Christy J. Oliger insider trades
Open-market stock purchases and sales by Christy J. Oliger, Director at Zenas BioPharma, Inc, from SEC Form 4 filings since Aug 28, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | ZBIO Zenas BioPharma, Inc | Bought (not open market) | — |
| Jul 28, 2026 | BCAX Bicara Therapeutics Inc | Bought (not open market) | — |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $164K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | — |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $462K |
| Jun 16, 2026 | NUVL Nuvalent, Inc | Bought (not open market) | — |
| May 21, 2026 | KPTI Karyopharm Therapeutics Inc | Bought (not open market) | — |
| May 21, 2026 | VERA Vera Therapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | REPL Replimune Group, Inc | Bought (not open market) | — |
| Nov 13, 2025 | LVTX LAVA Therapeutics NV | Sold (not open market) | — |
Companies traded
- ZBIO Zenas BioPharma, Inc: other filings, last Sep 1, 2026
- BCAX Bicara Therapeutics Inc: other filings, last Jul 28, 2026
- NUVL Nuvalent, Inc: other filings, last Jul 15, 2026
- KPTI Karyopharm Therapeutics Inc: other filings, last May 21, 2026
- VERA Vera Therapeutics, Inc: other filings, last May 21, 2026
- REPL Replimune Group, Inc: other filings, last Apr 1, 2026
- LVTX LAVA Therapeutics NV: other filings, last Nov 13, 2025
- RYZB RayzeBio, Inc: other filings, last Feb 26, 2024
- RETA Reata Pharmaceuticals Inc: other filings, last Sep 26, 2023
- SRRA Sierra Oncology, Inc: other filings, last Jul 1, 2022